Literature DB >> 29983197

Prone positioning before extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: A retrospective multicenter study.

W-Y Kim1, B J Kang2, C R Chung3, S H Park4, J Y Oh5, S Y Park6, W H Cho7, Y S Sim8, Y-J Cho9, S Park10, J-H Kim11, S-B Hong12.   

Abstract

OBJECTIVE: To evaluate the clinical outcomes of patients with severe acute respiratory distress syndrome (ARDS) subjected to prone positioning before extracorporeal membrane oxygenation (ECMO).
DESIGN: A retrospective analysis of a multicenter cohort was carried out.
SETTING: Patients admitted to the Intensive Care Units of 11 hospitals in Korea. PATIENTS: Patients were divided into those who underwent prone positioning before ECMO (n=28) and those who did not (n=34).
INTERVENTIONS: None. VARIABLES OF INTEREST: Thirty-day mortality, ECMO weaning failure rate, mechanical ventilation weaning success rate, mechanical ventilation-free days at day 60.
RESULTS: The prone group had lower median peak inspiratory pressure and lower median dynamic driving pressure before ECMO. Thirty-day mortality was 21% in the prone group and 41% in the non-prone group (p=0.098). The prone group also showed a lower ECMO weaning failure rate, and a higher mechanical ventilation weaning success rate and more mechanical ventilation-free days at day 60. In the non-prone group, median dynamic compliance marginally decreased shortly after ECMO, but no significant change was observed in the prone group.
CONCLUSIONS: Prone positioning before ECMO was not associated to increased mortality and tended to exert a protective effect.
Copyright © 2018 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.

Entities:  

Keywords:  Decúbito prono; Extracorporeal membrane oxygenation; Oxigenación con membrana extracorpórea; Prone position; Respiración, artificial; Respiration, artificial; Respiratory distress syndrome, adult; Síndrome de dificultad respiratoria, adulto

Mesh:

Year:  2018        PMID: 29983197     DOI: 10.1016/j.medin.2018.04.013

Source DB:  PubMed          Journal:  Med Intensiva (Engl Ed)        ISSN: 2173-5727


  5 in total

1.  Personalized mechanical ventilation for acute respiratory distress syndrome: are we ready?-Maybe.

Authors:  Won-Young Kim; Sang-Bum Hong
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

2.  Application of Hybrid Extracorporeal Membrane Oxygenation for the Treatment of Subsequent Shock following Acute Respiratory Distress Syndrome Developing after Firearm Injury.

Authors:  Yahya Yildiz; Didem Melis Oztas; Mustafa Ozer Ulukan; Korhan Erkanli; Orcun Unal; Murat Ugurlucan; Halil Turkoglu
Journal:  Case Rep Med       Date:  2019-12-04

3.  Extracorporeal Membrane Oxygenation in Immunocompromised Patients With Acute Respiratory Distress Syndrome-A Retrospective Cohort Study.

Authors:  Chiao-Feng Cheng; You-Yi Chen; Ming-Chieh Shih; Yi-Min Huang; Li-Jung Tseng; Chien-Heng Lai; Ting-Yuan Lan; Cheng-Hsun Lu; Song-Chou Hsieh; Ko-Jen Li; Nai-Hsin Chi; Hsi-Yu Yu; Yih-Sharng Chen; Chih-Hsien Wang
Journal:  Front Med (Lausanne)       Date:  2021-12-03

4.  Comparison of prone positioning and extracorporeal membrane oxygenation in acute respiratory distress syndrome: A multicenter cohort study and propensity-matched analysis.

Authors:  Ko-Wei Chang; Han-Chung Hu; Li-Chung Chiu; Ming-Cheng Chan; Shinn-Jye Liang; Kuang-Yao Yang; Wei-Chih Chen; Wen-Feng Fang; Yu-Mu Chen; Chau-Chyun Sheu; Wei-An Chang; Hao-Chien Wang; Ying-Chun Chien; Chung-Kan Peng; Chieh-Liang Wu; Kuo-Chin Kao
Journal:  J Formos Med Assoc       Date:  2021-10-16       Impact factor: 3.871

5.  Improvement in the survival rates of extracorporeal membrane oxygenation-supported respiratory failure patients: a multicenter retrospective study in Korean patients.

Authors:  Moon Seong Baek; Sang-Min Lee; Chi Ryang Chung; Woo Hyun Cho; Young-Jae Cho; Sunghoon Park; So-My Koo; Jae-Seung Jung; Seung Yong Park; Youjin Chang; Byung Ju Kang; Jung-Hyun Kim; Jin Young Oh; So Hee Park; Jung-Wan Yoo; Yun Su Sim; Sang-Bum Hong
Journal:  Crit Care       Date:  2019-01-03       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.